[New aspects of primary radiochemotherapy in head and neck cancer. Highlights from the 2011 ASCO Congress]. / Neue Aspekte der primären Radiochemotherapie bei Kopf-Hals-Tumoren. Highlights vom ASCO-Kongress 2011.
HNO
; 60(5): 393-7, 2012 May.
Article
em De
| MEDLINE
| ID: mdl-22570002
ABSTRACT
Primary radiochemotherapy is a treatment option for patients with locally advanced or unresectable head and neck cancer. Compared to conventional radiotherapy, intensity-modulated radiotherapy (IMRT) is associated with fewer long-term toxicities and better quality of life. Whether IMRT improves local control in these patients needs to be further investigated. The risk factors and treatment toxicities must be taken into consideration and discussed with the patients. New approaches combining radiotherapy and biological targets are a treatment option. The implementation of these substances in treatment protocols is increasing. Sensitive and specific prognostic biomarkers for patient identification to optimize treatment selection are important, but reliable parameters are still missing.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Radioterapia Conformacional
/
Quimiorradioterapia
/
Neoplasias de Cabeça e Pescoço
/
Antineoplásicos
Tipo de estudo:
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Humans
País/Região como assunto:
Europa
Idioma:
De
Revista:
HNO
Ano de publicação:
2012
Tipo de documento:
Article